A Study of Osivelotor (GBT021601) in Participants With Sickle Cell Disease (SCD)
An Open-label Extension Study to Evaluate the Long-term Safety of Osivelotor Administered to Participants With Sickle Cell Disease Who Have Participated in an Osivelotor Clinical Trial.
Category & Conditions: Immune System Diseases and Conditions
Medicine: OSIVELOTOR
ClinicalTrials.gov Identifier (NCT): NCT05632354
Protocol ID: C5351005 (GBT021601-022)
Open Plain Language Summary Result:
Click here